healthcare News
ProKidney maintains cash runway to 2027 despite wider quarterly loss
Biotech's Phase 3 kidney disease trial on track as FDA aligns on accelerated approval pathway
AbbVie slides 3.8% as J&J wins FDA approval for oral psoriasis drug
Icotyde becomes first oral peptide blocking IL-23 receptor, posing direct threat to AbbVie's $17.5B Skyrizi franchise
XOMA surges on Q4 earnings beat, swing to $31.7M profit
Royalty aggregator reverses 2024 loss as revenue jumps 83% and cash receipts top $50M
Trevi Therapeutics surges on earnings beat, FDA Phase 3 alignment
Biotech company ends 2025 with $188M cash runway as chronic cough treatment advances to pivotal trials
Kestra Medical Technologies surges 9.8% on revenue beat, lifted guidance
Wearable device maker raises full-year outlook as quarterly sales jump 63%, gross margins expand to 52.6%
AN2 Therapeutics soars 92% on $40M cash injection despite earnings miss
Pre-revenue biotech secures funding to extend runway into 2029, with three Phase 2 catalysts scheduled for 2026
Bicycle Therapeutics extends cash runway into 2030 after 30% job cuts
Biotech posts $48M Q4 revenue on Novartis/Bayer deal terminations, reprioritizes pipeline
Structure Therapeutics surges as oral GLP-1 shows 16.3% weight loss
Phase 2 trial results position aleniglipron against injectable leaders in expanding $73B market